Skip to content
Trial Eligibility
Menu

A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

NCT07244263

This study is recruiting at 4 US sites in 4 states, according to its ClinicalTrials.gov record last updated .

Summary

Hidradenitis Suppurativa (HS) is a skin condition that causes deep, painful bumps on the skin. These bumps usually appear in an area where the skin rubs together. They start as small bumps but may become swollen and red over time. If they fill with pus, these lumps are called abscesses; these can also burst. Over time, the area can get scars and tunnels on or under the skin. Recent studies suggest that the condition may start when hair follicles become damaged and blocked. This impacts the skin and may activate the body's germ-fighting (immune) system.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Hidradenitis Suppurativa

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Takeda
Last updated on ClinicalTrials.gov
March 6, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Arkansas · 1

  • Johnson Dermatology · Fort Smith, AR

California · 1

  • First OC Dermatology Research · Fountain Valley, CA

Florida · 1

  • Advanced Clinical Research Institute · Tampa, FL

New Hampshire · 1

  • StracSkin, PLLC · Greenland, NH

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.